Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.

Basit Öğe Kaydı
dc.authoridYILMAZ, Sedat/0000-0002-4691-3417
dc.authoridGul, Ahmet/0000-0001-8219-3720
dc.authoridHatemi, Gulen/0000-0002-1952-1135
dc.authoridYazıcı, Ayten/0000-0003-2167-4509;
dc.authorwosidOzguler, Yesim/AAE-9565-2019
dc.authorwosidYILMAZ, Sedat/JUV-4187-2023
dc.authorwosidGul, Ahmet/AAT-7787-2020
dc.authorwosidavci, ali berkant/C-7327-2016
dc.authorwosidDireskeneli, Haner/AAS-5508-2020
dc.authorwosidHatemi, Gulen/AFM-7014-2022
dc.authorwosidHatemi, Gulen/AAC-9647-2021
dc.contributor.authorKisacik, Bunyamin
dc.contributor.authorPamuk, Omer
dc.contributor.authorOnat, Ahmet Mesut
dc.contributor.authorErer, B.
dc.contributor.authorHatemi, Gulen
dc.contributor.authorOzguler, Yesim
dc.contributor.authorPehlivan, Yavuz
dc.date.accessioned2024-06-12T11:24:06Z
dc.date.available2024-06-12T11:24:06Z
dc.date.issued2014
dc.departmentTrakya Üniversitesien_US
dc.description78th Annual Meeting of the American-College-of-Rheumatology (ACR) / 49th Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP) -- NOV 14-19, 2014 -- Boston, MAen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Coll Rheumatol,Assoc Rheumatol Hlth Professen_US
dc.identifier.endpageS943en_US
dc.identifier.issn2326-5191
dc.identifier.issn2326-5205
dc.identifier.startpageS943en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/26806
dc.identifier.volume66en_US
dc.identifier.wosWOS:000344384904305en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofArthritis & Rheumatologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleTuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu